1,988 results
·
19ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
FDA Pre-Market Approval
FDA Class 3
·CLINICAL ASSAYS (TM) GAMMADAB(R) [ 125 I ]
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·TANDEM-R FREE PSA IMMUNORADIOMETRIC ASSAY/TANDEM-MP FREE PSA IMMUNOENZYMETRIC ASSAY
Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
FDA Pre-Market Approval
FDA Class 3
·ACCESS AFP REAGENTS ON THE ACCESS IMMUNOASSAY SYSTEMS
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·IMMULITE® 1000 Free PSA, IMMULITE® 2000 Free PSA
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA Pre-Market Approval
FDA Class 3
·ELECSYS TOTAL PSA IMMUNOASSAY
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION VISTA FPSA FLEX REAGENT CARTRIDGE
Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
FDA Pre-Market Approval
FDA Class 3
·AXSYM AFP
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·ARCHITECT FREE PSA
Total, Prostate Specific Antigen (Noncomplexed & Complexed) For Detection Of Prostate Cancer
FDA Pre-Market Approval
FDA Class 3
·ARCHITECT TOTAL PSA (LN 6CO6)
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION VISTA FPSA FLEX REAGENT CARTRIDGE
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA Pre-Market Approval
FDA Class 3
·DIMENSION FPSA FLEX REAGENT CARTRIDGE
P2psa
FDA Pre-Market Approval
FDA Class 3
·Access Hybritech p2PSA
Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
FDA classification
FDA Class 3
·Test, Hepatitis B (B Core, Be Antigen, Be Antibody, B Core Igm)
Antigen, Cancer 549
FDA classification
FDA Class 3
·Antigen, Cancer 549
Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection
FDA classification
FDA Class 3
·Rt-Pcr Multigene Expression Test, Sentinel Lymph Node, Cancer Metastasis Detection
Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer
FDA classification
FDA Class 3
·Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer
Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
FDA classification
FDA Class 3
·Kit, Test, Alpha-Fetoprotein For Neural Tube Defects
System, Test, Tumor Marker, For Detection Of Bladder Cancer
FDA classification
FDA Class 3
·System, Test, Tumor Marker, For Detection Of Bladder Cancer
Assays To Detect Pre-Existing Antibodies To Adeno-Associated Virus (Aav) Viral Vectors
FDA classification
FDA Class 3
·Assays To Detect Pre-Existing Antibodies To Adeno-Associated Virus (Aav) Viral Vectors
Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions
FDA classification
FDA Class 3
·Test, Prostate Specific Antigen, Free, (Noncomplexed) To Distinguish Prostate Cancer From Benign Conditions